ERBB2 and breast carcinoma: Further focusing on the subgroup of clinically node-positive HER2-positive and TN breast cancer patients, the AUC decreased slightly to 0.74 at a cut-off of 3.77 SUVmax measured on the most-FDG avid axillary lymph node.